An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published in the open-access journal PLOS Medicine by Leo Celi of the Massachusetts Institute of Technology, and colleagues.

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist shortage, a large new study finds.

The findings will be published on Thursday (June 5) in JAMA Network Open.

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm. A new study out today from York University found proactive, continual and transfer learning strategies for AI models to be key in mitigating data shifts and subsequent harms.

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence - could also be effective at treating cancer, a promising new approach to drug discovery.

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases.

The study published in the Journal of Health Organization and Management in May evaluated more than 7,000 anonymized medical queries from the United States and Australia.

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in diagnostics. The verdict? Patients are cautiously optimistic welcoming the potential benefits of AI but drawing a firm line: humans must stay in charge.

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow transplant (BMT). The researchers conducted a randomized clinical trial and found that caregivers assigned to use the app showed significantly greater improvements in quality of life, burden, and mood symptoms compared to those who did not have the app.